4.4 Article

Structure and Functional Characterization of the Conserved JAK Interaction Region in the Intrinsically Disordered N-Terminus of SOCS5

Journal

BIOCHEMISTRY
Volume 54, Issue 30, Pages 4672-4682

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.biochem.5b00619

Keywords

-

Funding

  1. National Health and Medical Research Council (NHMRC), Australia [1016647]
  2. NHMRC TRUSS Grant [361646]
  3. Cancer Council Victoria Grant [1065180]
  4. Victorian State Government Operational Infrastructure Scheme grant
  5. Australian Postgraduate Award
  6. NHMRC
  7. Australian Research Council

Ask authors/readers for more resources

SOCS5 can negatively regulate both JAK/STAT and EGF-receptor pathways and has therefore been implicated in regulating both the immune response and tumorigenesis. Understanding the molecular basis for SOCS5 activity may reveal novel ways to target key components of these signaling pathways. The N-terminal region of SOCS5 coordinates critical protein interactions involved in inhibition of JAK/STAT signaling, and a conserved region within the N-terminus of SOCS5 mediates direct binding to the JAK kinase domain. Here we have characterized the solution conformation of this conserved JAK interaction region (JIR) within the largely disordered N-terminus of SOCS5. Using nuclear magnetic resonance (NMR) chemical shift analysis, relaxation measurements, and NOE analysis, we demonstrate the presence of preformed structural elements in the JIR of mouse SOCS5 (mSOCS5(175-244)), consisting of an a-helix encompassing residues 224-233, preceded by a turn and an extended structure. We have identified a phosphorylation site (Ser211) within the JIR of mSOCS5 and have investigated the role of phosphorylation in modulating JAK binding using site-directed mutagenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Endothelial Caspase-8 prevents fatal necroptotic hemorrhage caused by commensal bacteria

Stefanie M. Bader, Simon P. Preston, Katie Saliba, Adam Lipszyc, Zoe L. Grant, Liana Mackiewicz, Andrew Baldi, Anne Hempel, Michelle P. Clark, Thanushi Peiris, William Clow, Jan Bjelic, Michael D. Stutz, Philip Arandjelovic, Jack Teale, Fashuo Du, Leigh Coultas, James M. Murphy, Cody C. Allison, Marc Pellegrini, Andre L. Samson

Summary: Caspase-8 mediates various responses including inflammation, cell proliferation, and cell death. Its function during embryogenesis is essential for maintaining systemic circulatory system, while in adulthood it is crucial for preserving gut vascular integrity. Lack of endothelial Caspase-8 leads to fatal hemorrhagic lesions in the small intestine, resulting from aberrant microbial sensing and tumor necrosis factor receptor signaling.

CELL DEATH AND DIFFERENTIATION (2023)

Review Cell Biology

The web of death: the expanding complexity of necroptotic signaling

Christopher R. Horne, Andre L. Samson, James M. Murphy

Summary: In the past decade, the importance of the necroptosis programmed cell death pathway in the pathophysiology of various diseases has been confirmed. The receptor interacting protein kinase (RIPK)1 and RIPK3, and the pseudokinase executioner protein, mixed lineage kinase domain-like (MLKL), have emerged as core components of the pathway. These proteins also serve as integrators of signals and add complexity to pathway regulation. This article describes the emerging concept of the protein network that tunes necroptotic signal transduction and how these events have diverged across species, possibly due to selective pressures from pathogens on the RIPK3-MLKL protein pair.

TRENDS IN CELL BIOLOGY (2023)

Article Biochemistry & Molecular Biology

Caspase-8-driven apoptotic and pyroptotic crosstalk causes cell death and IL-1β release in X-linked inhibitor of apoptosis (XIAP) deficiency

Sebastian A. Hughes, Meng Lin, Ashley Weir, Bing Huang, Liya Xiong, Ngee Kiat Chua, Jiyi Pang, Jascinta P. Santavanond, Rochelle Tixeira, Marcel Doerflinger, Yexuan Deng, Chien-Hsiung Yu, Natasha Silke, Stephanie A. Conos, Daniel Frank, Daniel S. Simpson, James M. Murphy, Kate E. Lawlor, Jaclyn S. Pearson, John Silke, Marc Pellegrini, Marco Herold, Ivan K. H. Poon, Seth L. Masters, Mingsong Li, Qin Tang, Yuxia Zhang, Maryam Rashidi, Lanlan Geng, James E. Vince

Summary: This study reveals that genetic mutations in X-linked inhibitor of apoptosis (XIAP) can lead to cell death-associated inflammatory diseases. The findings show that patients with XIAP deficiency-associated inflammatory bowel disease have increased inflammatory IL-1 beta maturation and cell death-associated caspase-8 and Gasdermin D (GSDMD) processing, which can be reduced by patient treatment.

EMBO JOURNAL (2023)

Article Medicine, Research & Experimental

A Biodistribution Study of the Radiolabeled Kv1.3-Blocking Peptide DOTA-HsTX1[R14A] Demonstrates Brain Uptake in a Mouse Model of Neuroinflammation

Sanjeevini Babu Reddiar, Michael de Veer, Brett M. Paterson, Tara Sepehrizadeh, Dorothy C. C. Wai, Agota Csoti, Gyorgy Panyi, Joseph A. Nicolazzo, Raymond S. Norton

Summary: This study investigates the in vivo distribution of HsTX1[R14A] peptide in mice and finds increased uptake in a LPS-induced mouse model of neuroinflammation, as well as accumulation in inflamed joints.

MOLECULAR PHARMACEUTICS (2023)

Review Urology & Nephrology

Role of necroptosis in kidney health and disease

Benedikt Kolbrink, Friedrich A. von Samson-Himmelstjerna, James M. Murphy, Stefan Krautwald

Summary: Cell death, particularly tubule epithelial cell death, plays a critical role in the pathophysiology of kidney disease. Accumulated evidence has shown that necroptosis, a form of regulated necrosis, is involved in acute tubular necrosis, nephron loss, and renal fibrogenesis. Unlike apoptosis, necroptosis triggers an inflammatory response due to the release of cellular contents and cytokines. Despite the link between necroptosis and kidney diseases, therapeutic options targeting this process are currently unavailable. Further understanding of the molecular mechanisms and regulators of necroptosis may lead to innovative therapeutic approaches.

NATURE REVIEWS NEPHROLOGY (2023)

Article Biochemistry & Molecular Biology

Design and characterization of a heterobifunctional degrader of KEAP1

Hao Chen, Nghi H. Nguyen, Charlene M. Magtoto, Simon A. Cobbold, Grace M. Bidgood, Lizeth G. Meza Guzman, Lachlan W. Richardson, Jason Corbin, Amanda E. Au, Bernhard C. Lechtenberg, Rebecca Feltham, Kate D. Sutherland, Christoph Grohmann, Sandra E. Nicholson, Brad E. Sleebs

Summary: A proteolysis targeting chimera (PROTAC) that depletes KEAP1 and activates the NRF2 antioxidant response has been developed as a potential strategy to treat diseases caused by oxidative stress. The optimized PROTAC 14 demonstrated potent KEAP1 degradation and increased expression of antioxidant proteins, effectively preventing cell death induced by reactive oxygen species. This approach presents an alternative therapeutic strategy for oxidative stress-related diseases.

REDOX BIOLOGY (2023)

Article Chemistry, Medicinal

Interaction of the Inhibitory Peptides ShK and HmK with the Voltage-Gated Potassium Channel KV1.3: Role of Conformational Dynamics

Karoline Sanches, Viktor Prypoten, K. George Chandy, David K. Chalmers, Raymond S. Norton

Summary: Peptide toxins like ShK can inhibit the KV1.3 potassium channel and may have potential therapeutic applications for autoimmune and neuroinflammatory diseases. ShK and its homolog HmK exhibit different dynamic behaviors, with ShK showing higher affinity for the KV1.3 channel.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2023)

Article Chemistry, Medicinal

From (Tool)Bench to Bedside: The Potential of Necroptosis Inhibitors

Christopher R. Gardner, Katherine A. Davies, Ying Zhang, Martin Brzozowski, Peter E. Czabotar, James M. Murphy, Guillaume Lessene

Summary: Necroptosis is a regulated caspase-independent form of necrotic cell death that leads to an inflammatory phenotype. It plays a significant role in the pathophysiology of various diseases. The key components of necroptosis signaling, such as RIPK1, RIPK3, and MLKL, have been identified, and they hold promise as therapeutic targets.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Multidisciplinary Sciences

Inside-out: Antibody-binding reveals potential folding hinge-points within the SARS-CoV-2 replication co-factor nsp9

Yue R. Pan, Indu Chandrashekaran, Luke Tennant, Jamie Rossjohn, Dene Littler

Summary: Nsp9 is an important component in coronaviral replication and transcription complex. It facilitates nucleotidylation activity of nsp12 and recruits proteins necessary for viral 5'-capping. Antibodies targeting nsp9 can induce significant changes in its overall structure and dynamics, particularly in the cavity between s2-s3 and s4-s5 loops and the C-terminal GxxxG helix.

PLOS ONE (2023)

Article Food Science & Technology

Acontia, a Specialised Defensive Structure, Has Low Venom Complexity in Calliactis polypus

Hayden L. Smith, Peter J. Prentis, Scott E. Bryan, Raymond S. Norton, Daniel A. Broszczak

Summary: The venom delivery system of Phylum Cnidaria is unique, consisting of individual organelles known as nematocysts. Acontia, found in a limited number of sea anemone species, are packed with large nematocysts used for defense. This study identified the venom profile of acontia in Calliactis polypus, revealing limited toxin diversity and a novel toxin with two ShK-like domains. This research provides a foundation for further investigating the function of acontial toxins in sea anemones.

TOXINS (2023)

Review Biochemistry & Molecular Biology

Structure of the voltage-gated potassium channel KV1.3: Insights into the inactivated conformation and binding to therapeutic leads

K. George Chandy, Karoline Sanches, Raymond S. Norton

Summary: The voltage-gated potassium channel K(V)1.3 is an important therapeutic target for autoimmune and neuroinflammatory diseases. Recent structural studies have provided insights into the conformational changes of the channel and the mechanism of ion permeation. These findings contribute to a better understanding of the slow inactivation mechanism of K(V) channels and can guide the development of future immunotherapeutics targeting K(V)1.3.

CHANNELS (2023)

Article Biochemistry & Molecular Biology

Structure-function relationships in ShKT domain peptides: ShKT-Ts1 from the sea anemone Telmatactis stephensoni

Karoline Sanches, Lauren M. Ashwood, Abisola Ave-Maria Olushola-Siedoks, Dorothy C. C. Wai, Arfatur Rahman, Kashmala Shakeel, Muhammad Umair Naseem, Gyorgy Panyi, Peter J. Prentis, Raymond S. Norton

Summary: Diverse structural scaffolds have been found in peptides from sea anemones, including the common ShKT scaffold. While some ShKT peptides from sea anemones inhibit K-V 1.x channels, others do not. Using NMR and molecular dynamics simulations, a new ShKT peptide from the sea anemone Telmatactis stephensoni was studied and found to have no activity against K-V 1.x channels. The exposure of dyad residues during MD simulations is correlated with the ability of ShKT peptides to block K-V 1.x channels.

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2023)

Article Multidisciplinary Sciences

A small molecule inhibitor of PTP1B and PTPN2 enhances T cell anti-tumor immunity

Shuwei Liang, Eric Tran, Xin Du, Jiajun Dong, Harrison Sudholz, Hao Chen, Zihan Qu, Nicholas D. Huntington, Jeffrey J. Babon, Nadia J. Kershaw, Zhong-Yin Zhang, Jonathan B. Baell, Florian Wiede, Tony Tiganis

Summary: In this study, the authors demonstrate that inhibition of PTP1B and PTPN2 in tumor cells and T cells with a small molecule inhibitor represses the growth of immunogenic and cold tumors, and enhances response to anti-PD-1 immunotherapy without promoting immune-related toxicities.

NATURE COMMUNICATIONS (2023)

Article Biochemistry & Molecular Biology

Fragment screening libraries for the identification of protein hot spots and their minimal binding pharmacophores

Rebecca L. L. Whitehouse, Wesam S. S. Alwan, Olga V. V. Ilyichova, Ashley J. J. Taylor, Indu R. R. Chandrashekaran, Biswaranjan Mohanty, Bradley C. C. Doak, Martin J. J. Scanlon

Summary: Fragment-based drug design relies on structural information obtained through X-ray crystallography to evolve fragments into lead-like compounds through structure-based design. The composition of compound libraries can be optimized to probe binding hot spots on protein surfaces.

RSC MEDICINAL CHEMISTRY (2023)

No Data Available